HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunohistochemical study of cytokeratin expression in nevus sebaceous.

AbstractBACKGROUND:
The histogenesis of nevus sebaceous (NS) is unclear.
METHODS:
To elucidate the histogenesis of NS, cytokeratin (CK) profiles were examined immunohistochemically using 10 anti-keratin antibodies in the three stages of NS.
RESULTS:
In the first stage, stratified differentiated keratins (CK1 and 10) were reduced, and basal keratin (CK14) was increased in the epidermis and primitive follicular structure (PFS). In the second stage, in addition to reduced CK1 and CK10 expressions and increased CK14 expression, CK17 expression was strongly expressed in the sebaceous ducts in proportion to the development of sebaceous gland. In the third stage, CK14, CK17 and CK19 were expressed in secondary tumors. CK16 was not detected throughout all stages of NS.
CONCLUSION:
These results suggest that NS is not hyperproliferative but involves hamartomatous differentiation with undifferentiated keratins.
AuthorsIchiro Kurokawa, Keisuke Nishimura, Kei-ichi Yamanaka, Ken-ichi Isoda, Yoshiki Taniguchi, Daisuke Tsuruta, Airo Tsubura, Hitoshi Mizutani
JournalInternational journal of dermatology (Int J Dermatol) Vol. 49 Issue 4 Pg. 402-5 (Apr 2010) ISSN: 1365-4632 [Electronic] England
PMID20465694 (Publication Type: Journal Article)
Chemical References
  • Keratin-14
  • Keratin-16
  • Keratin-17
  • Keratins
Topics
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Epidermis (metabolism)
  • Female
  • Humans
  • Immunohistochemistry
  • Keratin-14 (metabolism)
  • Keratin-16 (metabolism)
  • Keratin-17 (metabolism)
  • Keratins (metabolism)
  • Male
  • Middle Aged
  • Nevus, Sebaceous of Jadassohn (metabolism, pathology)
  • Sebaceous Glands (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: